Cerus Corp (CERS) - 3Q earnings report Oct 28, 2010

Cerus Corp (CERS) is scheduled to release its earnings report next week on Oct 28, 2010 AFTER the closing bell.  A live webcast will be hosted by the company at 4:15 pm ET.  The blood component-separation specialty biotech has been on a rising trend due to positive large-scale clinical study results and consistent expansion in product sales.

    "This [latest] study demonstrates that INTERCEPT can be implemented into routine practice, providing protection against transfusion-transmitted pathogens, without impacting either platelet or red blood cell utilization. This observation confirms previous data indicating that the treated platelets are functioning similarly to untreated platelets," said Dr. Laurence Corash, Cerus' chief medical officer.

"Post-earnings boost"
What followed each financial statement release in the past 4 quarters interestingly was always a 'post-earnings boost' in Cerus' stock as investors became more and more confident of the company's product market potential (read more about Cerus' INTERCEPT blood system).

With the next quarterly statement due next Thursday, today's 4.45% dip may represent a discount for those desiring to catch the pre-earnings ride.